Good News for Rheumatoid Arthritis Sufferers…

Current Studies:

Do you suffer from rheumatoid arthritis?  Does your rheumatoid arthritis keep you from enjoying your daily activities?  If so, our clinical research study may be an option for you.  We are currently enrolling participants in a research study of an investigational drug.  If you are at least 18 years of age and you are currently taking methotrexate you may qualify.  Qualified participants will receive all office visits, lab work, and study drug at no cost.  You may receive compensation.  To learn more call the Arthritis and Osteoporosis Center of Maryland today at 1-888-71 STUDY.  That’s 1-888-71 STUDY

Participate today for a healthier tomorrow.

Pfizer A6

Do you suffer from Rheumatoid Arthritis?

If you have been diagnosed with rheumatoid arthritis, you may be interested in a 48 week research study being conducted right now in Frederick, MD.

Are you age 18 and over, are currently taking methotrexate you may be qualified to participate in this study.

Qualified participants will receive study visits, lab work, and study-related drug at no charge.  You may be compensated for traveling expenses.

To learn more about this study, please call 301-624-1164 or 1-888-71 STUDY.

RG 

Are you suffering with Rheumatoid Arthritis?

Rheumatoid Arthritis affects approximately 1% of the population worldwide. The clinical onset often involves gradual joint destruction and deformity causing pain, stiffness and may result in functional disability.

The Arthritis and Osteoporosis Center of Maryland  is participating in a worldwide research study for patients with Rheumatoid Arthritis.  The purpose of this research study is to evaluate the safety and effectiveness of three different dose regimens of an investigational medication.  Patients may be randomized to placebo or one of the three dose regimens of an investigational medication.

      To qualify for the study you must be:

·        At least 18 years of age

·        Diagnosed with Rheumatoid Arthritis for at least a year

·        Previously treated (current or past treatment) with Enbrel (etanercept), Humira (adalimumab), or Remicade (infliximab) without acceptable benefit (ineffective.)

·        Presently on a stable dose of one of the Disease Modifying Anti-Rheumatic Drugs (DMARD) such as methotrexate

Qualified participants receive study-related office visits and study medication at no cost and may receive compensation for travel expenses.  If you are interested in receiving more information about this study, call the Arthritis and Osteoporosis Center of Maryland at 301-694-5800.

SO

Arthritis and Osteoporosis Center of Maryland
71 Thomas Johnson Drive
Frederick, Maryland 21702

301-694-5800
1-888-863-7646 (Toll Free Line)
1-888-71-STUDY (Clinical Study Line)

aocmd@aocm.org

Please call our 24-hour, toll-free hotline for requesting FREE information on knee pain and arthritis. (1-888-863-7646)

© 2002 AOCM
All rights reserved.